Endothelial and epithelial expression of eotaxin-2 (CCL24) in nasal polyps

International Archives of Allergy and Immunology

Volumn 140, Issue 3, 2006, Pages 205-214

  Schaefer, D ^a   Meyer, J E ^b   Pods, R ^b   Pethe, W ^b   Hedderich, J ^b   Schmidt, C ^b   Maune, S ^b  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b UNIVERSITY OF KIEL   (Germany)

Author keywords

CCL11; CCL24; Chemokines; Chronic nasal polyposis; Eosinophilia; Eotaxin; Sinusitis

Indexed keywords

CHEMOKINE; CHEMOKINE CCL24; EOTAXIN; EOTAXIN 2; GAMMA INTERFERON; INTERLEUKIN 4; MESSENGER RNA; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; CELL CULTURE; CELL MIGRATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHILIA; EPITHELIUM; EPITHELIUM CELL; FEMALE; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MALE; NOSE POLYP; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHOOL CHILD; SINUSITIS; TURBINATE;

ADOLESCENT; ADULT; AGED; CHEMOKINES, CC; CHILD; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITHELIAL CELLS; FEMALE; FIBROBLASTS; HUMANS; IMMUNOHISTOCHEMISTRY; INTERFERON TYPE II; INTERLEUKIN-4; MALE; MIDDLE AGED; NASAL MUCOSA; NASAL POLYPS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33745088641     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000093206     Document Type: Article

References (27)

1. Larsen K, Tos M: The estimated incidence of symptomatic nasal polyps. Acta Otolaryngol 2002;122:179-182.
2. Widal F, Abrami P, Lemoyer J: First complete description of the aspirin idiosyncrasy-asthma-nasal polyposis syndrome (plus urticaria) - 1922 (with a note on aspirin desensitisation. J Asthma 1987;24:297-300.
3. Coste A, Rateau JG, Roudot-Thoraval F, Chapelin C, Gilain L, Poron F, Peynegre R, Bernaudin JF, Escudier E: Increased epithelial cell proliferation in nasal polyps. Arch Otolaryngol Head Neck Surg 1996;122:432-436.
4. Larsen PL, Tingsgaard PK, Harcourt J, Sofsrud G, Tos M: Nasal polyps and their relation to polyps/hypertrophic polypoid mucosa in the paranasal sinuses: a macro-, endo-, and microscopic study of autopsy materials. Am J Rhinol 1998;12:45-51.
5. Bachert C, Wagenmann M, Hauser U, Rudack C: IL-5 synthesis is upregulated in human nasal polyp tissue. J Allergy Clin Immunol 1997;99:837-842.
6. Simon HU, Yousefi S, Schranz C, Schapowal A, Bachert C, Blaser K: Direct demonstration of delayed eosinophil apoptosis as a mechanism causing tissue eosinophilia. Immunol J 1997;158:3902-3908.
7. Mygind N: Nasal polyposis. J Allergy Clin Immunol 1990;86:827-829.
8. Tos M: Nasal polyps. Curr Opin Otolaryngol Head Neck Surg 1995;3:31-35.
9. Bachert C, Gevaert P, Holtappels G, Cuvelier P, van Cauwenberge: Nasal polyposis: from cytokines to growth. Am J Rhinol 2000;14:279-290.
10. Shin S, Park J, Jeon C: Quantitative analysis of eotaxin and RANTES messenger RNA in nasal polyps: association of tissue and nasal eosinophils. Laryngoscope 2000;110:353-357.
11. Ebisawa M, Yamada T, Bickel C, Klunk D, Schleimer RP: Eosinophil transendothelial migration induced by cytokines. III. Effect of the chemokine RANTES. J Immunol 1994;153:2153-2160.
12. Teran LM, Mochizuki M, Bartels J, Valencia EL, Nakajima T, Hirai K, Schroeder JM: Th1-and Th2-type cytokines regulate the expression and production of eotaxin and RANTES by human lung fibroblasts. Am J Respir Cell Mol Biol 1999;20:777-780.
13. Forssman U: Eotaxin-2, a novel CC chemokine that is selective for the chemokine receptor CCR-3, and acts like eotaxin on human eosinophil and basophil leukocytes. J Exp Med 1997;185:2171-2176.
14. White JR, Imburgia C, Dul E, Appelbaum E, O'Donnel K, O'Shannessy J, Brawner M, Fornwald J, Adamou J, Elshourbagy NA, Kaiser K, Foley JJ, Schmidt DB, Johanson K, Macphee C, Moores K, McNulty D, Scott GF, Schleimer RP, Sarau HM: Cloning and functional characterization of a novel human CC chemokine that binds to the CCR3 receptor and activates human eosinophils. J Leukoc Biol 1997;62:667-675.
15. Bartels J, Maune S, Meyer JE: Increased eotaxin mRNA expression in non-atopic and atopic nasal polyps: comparison to RANTES and MCP-3 expression. Rhinolaryngology 1997;35:171-174.
16. Ying S, Meng Q, Zeibecoglou K, Robinson DS, Macfarlane A, Hembert M, Kay AB: Eosinophil chemotactic chemokines (eotaxin, eotaxin-2, RANTES, monocyte chemoattractant protein 3 (MCP-3), and MCP-4), and C-C chemokine receptor 3 expression in bronchial biopsies from atopic and nonatopic (intrinsic) asthmatics. J Immunol 1999;163:6321-6329.
17. Maune S, Pods R, Bartels J, Schröder JM: Nasale Fibroblasten sind eine Quelle für Eotaxin-mRNA-Genexpression. Allergologie 1999;8:477-480.
18. Papadopoulos NG, Papi A, Meyer J, Stanciu LA, Salvi S, Holgate ST, Johnston SL: Rhino-virus infection up-regulates eotaxin and eotaxin-2 expression in bronchial epithelial cells. Clin Exp Allergy 2000;31:1060-1066.
19. Jahnsen F, Haye R, Gran E, Brandtzaeg P, Johansen FE: Glucocorticoids inhibit mRNA expression for eotaxin, eotaxin-2 and MCP-4 in human inflammation with eosinophilia. J Immunol 1999;165:1545-1551.
20. Mattinger C, Nyugen T, Schäfer D, Hörmann K: Evaluation of serum-free culture conditions for primary human nasal epithelial cells. J Environ Health 2002;205:235-238.
21. Pods R, Ross D, van Huelst S, Rudack C, Maune S: RANTES, eotaxin and eotaxin-2 expression and production in patients with aspirin triad. Allergy 2003;58:1165-1170.
22. Chomczynski P, Sacchi N: Single-step method of RNA isolation by guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-159.
23. Rothenberg ME: Eotaxin: an essential mediator of eosinophil trafficking into mucosal tissues. Am J Respir Cell Mol Biol 1999;21:291-295.
24. Maune S, Meyer JE, Sticherling M, Fölster-Holst R, Schröder JM: Eosinophilen chemotaktische Aktivität in der Chemokinfraktion von Nasenpolypen. Allergologie 1996;19:230-233.
25. Caversaccio M, Hartnell A, Calman D, Jose P, Mackey IS, Uggucioni M, Williams TJ, Conroy DM: The role of chemokines in nasal polyps. Schweiz Med Wochenschr 2000;125:92S-95S.
26. Ponath PD, Qin SX, Ringler DJ, Clark-Lewis J, Wang J, Kassam N, Smith H, Shi XJ, Gonzales JA, Newman W, Gutierrez-Ramos JC, Mackey CR: Cloning of the human eosinophil chemoattractant, eotaxin. Expression, receptor binding, and functional properties suggest a mechanism for the selective recruitment of eosinophils. J Clin Invest 1997;97:604-612.
27. Moshizuki M, Bartels J, Mallet AJ, Christophers E, Schröder JM: Interleukin-4 selectively induces eotaxin in dermal fibroblasts: a possible mechanism of eosinophil recruitment in parasite defense, allergic and atopic skin disease. J Immunol 1998;160:60-68.